Return to Home Incidence > Table > Interpret

Interpretation of Incidence Rates Data

Incidence Rate Report by State

Breast (in situ) (All Stages^), 2017-2021

All Races (includes Hispanic), Female, All Ages

Sorted by Count

Explanation of Column Headers

Objective - The objective of *** is from the Healthy People 2020 project done by the Centers for Disease Control and Prevention.

Incidence Rate (95% Confidence Interval) - The incidence rate is based upon 100,000 people and is an annual rate (or average annual rate) based on the time period indicated. Rates are age-adjusted by 5-year age groups to the 2000 U.S. standard million population.

Recent Trends - This is an interpretation of the AAPC/APC:

AAPC/APC (95% Confidence Interval) - the change in rate over time


Other Notes


Line by Line Interpretation of the Report


US (SEER+NPCR)1


Wyoming6


Alaska6


Vermont6


North Dakota6


District of Columbia6


South Dakota6


Montana6


Delaware6


New Mexico7


Rhode Island6


Maine6


Idaho7


West Virginia6


New Hampshire6


Nebraska6


Hawaii7


Utah7


Nevada6


Puerto Rico6


Kansas6


Mississippi6


Oklahoma6


Arkansas6


Iowa7


Oregon6


Louisiana7


Alabama6


Kentucky7


Colorado6


Connecticut7


Minnesota6


Tennessee6


South Carolina6


Missouri6


Arizona6


Maryland6


Wisconsin6


Washington5


Massachusetts7


Virginia6


Georgia7


Michigan6


Ohio6


North Carolina6


New Jersey7


Illinois7


Pennsylvania6


Texas7


Florida6


New York7


California7


Indiana6

Notes:
Created by statecancerprofiles.cancer.gov on 10/07/2024 4:09 pm.

State Cancer Registries may provide more current or more local data.

Data cannot be shown for the following areas. For more information on what areas are suppressed or not available, please refer to the table.
Indiana

† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used for SEER and NPCR incidence rates.
Rates and trends are computed using different standards for malignancy. For more information see malignant.html.

^ All Stages refers to any stage in the Surveillance, Epidemiology, and End Results (SEER) Summary/Historic Combined Summary Stage (2004+).
* Data has been suppressed to ensure confidentiality and stability of rate estimates. Counts are suppressed if fewer than 16 records were reported in a specific area-sex-race category. If an average count of 3 is shown, the total number of cases for the time period is 16 or more which exceeds suppression threshold (but is rounded to 3).
Data not available for this combination of data selections.
Source: SEER and NPCR data. For more specific information please see the table.

Data for the United States does not include data from Indiana.
Data for the United States does not include Puerto Rico.